Skip to main content
Fig. 1 | BMC Gastroenterology

Fig. 1

From: Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort

Fig. 1

Efficacy of treatment of the study patients. Sustained virological response rates after 12 weeks after the end of treatment (SVR 12) are shown for patients with HCV genotype 1, 2, 3 or 4 (a–d). Patients were sub-classified for previous treatment experience or presence of cirrhosis. n = total number of patients

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us